The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DNA methylation signature to define cell ontogeny of renal cell carcinomas.
 
Gabriel G. Malouf
Honoraria - GlaxoSmithKline; Janssen; Novartis; Roche
Consulting or Advisory Role - Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Janssen; Novartis; Pfizer
 
Xiaoping Su
No Relationships to Disclose
 
Jianping Zhang
No Relationships to Disclose
 
Thai Huu Ho
No Relationships to Disclose
 
Yue Lu
No Relationships to Disclose
 
Noel J-M Raynal
No Relationships to Disclose
 
Jose A Karam
No Relationships to Disclose
 
Pheroze Tamboli
No Relationships to Disclose
 
Frederick Allanick
No Relationships to Disclose
 
Roger Mouawad
No Relationships to Disclose
 
David Khayat
Stock and Other Ownership Interests - Agenus
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Celgene; Equatour; genomic health; Laval Sante; SOFIE
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Jaroslav Jelinek
No Relationships to Disclose
 
Nizar M. Tannir
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Pfizer
Travel, Accommodations, Expenses - Exelixis; GlaxoSmithKline; Novartis; Pfizer